Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al

$25.00

v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008

SKU: v14i3porter Categories: ,
Authors

Stenan D. Porter

Classification

Antitrust

Publication Year

2008